Miller Michael Patrick
CIK 0001236514
Director
Filings
13
Latest May 19, 2026
Issuers covered
3
Showing
13 of 13
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 60% | -4.0% | +0.9% | +28.0% | -44.1% |
| 90 days | 5 | 60% | -18.0% | +2.4% | +4.9% | -68.3% |
| 180 days | 5 | 40% | -15.3% | -8.3% | +19.9% | -59.3% |
| 365 days | 4 | 25% | -7.3% | -4.0% | +19.2% | -40.3% |
Issuers
Companies where Miller Michael Patrick has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PBYI | Puma Biotechnology, Inc. | 8 | Nov 13, 2025 |
| BTAI | Bioxcel Therapeutics, Inc. | 3 | Jan 12, 2026 |
| RIGL | Rigel Pharmaceuticals Inc | 2 | May 19, 2026 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|